# Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

> **NCT02481219** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 122 (actual)

## Conditions studied

- Colorectal Cancer Screening

## Interventions

- **DEVICE:** PillCam® COLON 2 procedure-CONTROL
- **DRUG:** Senna tablets
- **DRUG:** PEG
- **DRUG:** Metoclopramide
- **DRUG:** Erythromycin
- **DRUG:** SUPREP oral sulfate solution
- **DRUG:** Bisacodyl
- **DRUG:** SUPREP oral sulfate solution with Gastrografin

## Key facts

- **NCT ID:** NCT02481219
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2017-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481219, "Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02481219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*